New combination approved by MFDS for s-amlodipine/valsartan

Published: 2013-08-14 06:57:00

Updated: 2013-08-14 06:57:00

Ahngook Pharm said on Tuesday that the Ministry of Food and Drug Safety (MFDS) had given the green light to Levosartan, which combines the two most commonly prescribed hypertension medicines in one tablet (5mg/160mg, 2.5mg/160mg and 2.5mg/80mg), and that it would be available from October.

Levosartan is a combined formulation of s-amlodipine besylate, a dihydropyridine calcium-channel block...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.